Business Oregon and the Oregon Clinical and Translational Research Institute’s (OCTRI) Biomedical Innovation Program (BIP) are pleased to announce the continuation and expansion of their pilot program to help Oregon small businesses access federal funding through successful Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grant applications. As of Sept. 8, 2015, Oregon small businesses in the health care technology industry that meet the federal SBIR/STTR guidelines are eligible to apply.
The specific goal of the Phase 0 program is to improve the competitiveness of SBIR/STTR applications and lead to award funding. The Phase 0 program provides expert reviews of draft SBIR/STTR grant proposals, as well as support for proposal development.
Grant review benefits include:
- Strategic advice from experienced translational scientists
- Writing guidance and feedback on grant structure, based on NIH review criteria
- Identification of potential scientific consultants or advisors
- Recommendations for additional preliminary studies or data analysis
- Application weaknesses highlighted prior to submission
In addition to the services provided by reviewers, Phase 0 program applicants can request up to $3,725 for SBIR/STTR grant application preparation services. Please see the complete request for applications for allowable expenses.
The program thus far has supported four Oregon companies submitting SBIR or STTR applications. Becky Voorheis, CEO of Quickbeam and an SBIR Phase 0 awardee, said about the program: “I can’t overstate how valuable the Phase 0 grant was to us in the grant preparation. We received extremely high quality feedback and support from our reviewers.”
Apply now! Phase 0 submissions must be received a minimum of nine weeks prior to SBIR/STTR due date (Nov. 3, 2015 for the NIH SBIR/STTR; Jan. 5, 2016 deadline).
Please direct program inquiries to:
Jonathan Jubera, OHSU Biomedical Innovation Program
Mark Brady, Business Oregon